We found that among CD8+ T cell subsets, Compared with healthy controls and HBV-LC patients, TEMRA was significantly increased in PBMCs of HBV-HCC patients, which is consistent with previous findings (38), which may be related to the decreased recruitment of TEMRA to tumor sites. This evidence concerns the gene CD8A and laryngotracheoesophageal cleft.